With regulators embracing next-generation sequencing, how will the ICH Q5A(R2) guidelines reshape viral safety strategies for gene and cell therapies?
Sandra Zucchet, MSc
Advertisement
Articles by Sandra Zucchet, MSc
Advertisement
Latest Updated Articles
Viral Clearance & Viral Safety: Industry Trends & Key EventsPublished: May 9th 2025 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5
